20 Recruiting Neurofibromatosis 1 Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Interventions for Neurofibromatosis 1
Top Recruiting Neurofibromatosis 1 Studies
Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1
📍 Johns Hopkins University — Baltimore, Maryland
View Study & Checklist ➔Whole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
📍 Children's National Health System — Washington D.C., District of Columbia
View Study & Checklist ➔NF-1, Nutraceutical Intervention
📍 Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota
View Study & Checklist ➔AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
📍 Children's National Medical Center — Washington D.C., District of Columbia
View Study & Checklist ➔Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas
📍 Research Site — Gainesville, Florida
View Study & Checklist ➔Study to Evaluate the Safety, Tolerability, PK Characteristics and Anti-tumor Activity of FCN-159 in Adult and Pediatric Participants With Neurofibromatosis Type 1
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
📍 Childrens of Alabama — Birmingham, Alabama
View Study & Checklist ➔Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
📍 Childrens of Alabama — Birmingham, Alabama
View Study & Checklist ➔Neurofibromatosis (NF) Registry Portal
📍 Children's Tumor Fundation — New York, New York
View Study & Checklist ➔Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
📍 Children's National Medical Center — Washington D.C., District of Columbia
View Study & Checklist ➔Acceptance and Commitment Therapy for Caregivers of Children With a RASopathy: An Internal Pilot Feasibility Study and Follow-up Randomized Controlled Trial
📍 National Cancer Institute (NCI) — Bethesda, Maryland
View Study & Checklist ➔